N/A (healthy adults)
Conditions
Interventions
Oral intake of the test product (4 weeks)
Sponsors
LAIMU Corporation
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: [1]Japanese males and females aged 20-59 years [2]Healthy individuals without chronic diseases, including eye and skin disorders [3]Individuals who have dry eye like symptoms in their daily lives (tired eyes, rough eyes, eye dry feeling, discomfort in eyes, tingling in eyes, red eyes, difficulty in opening eyes in the morning, crumpled eyes, etc.) [4]Individuals who works with VDT (Visual Display Terminals) for 5 days or more a week (in total 20 hours or more a week including video games, PC and mobile phone operation time) [5]Individuals with corrected visual acuity of 1.0 or higher who are not wearing contact lenses or who can change to eyeglasses during the study period [6]Individuals voluntarily to join the study with written informed consent [7]Individuals who can visit study site and receive examinations on designated days [8]Individuals judged appropriate to join this study by principal investigators
Exclusion criteria
Exclusion criteria: [1]Individuals receiving medical drugs for treatment of chronic diseases [2]Individuals receiving/received medical drug treatment for the past 1 month except for temporary relief medication such as headache, menstrual pain, common cold, etc. [3]Individuals under treatment or with history of mental disorders, sleep disorders, hypertension, diabetes, lipid metabolism abnormality, or other serious disorders [4]Individuals with history of serious diseases (hepatic, renal, cardiovascular, respiratory, hematologic, etc.) [5]Individuals with history of gastrointestinal disorders except for appendicitis [6]Individuals who use artificial tears (eye drops) 6 times or more a day [7]Individuals diagnosed with presbyopia or aware of presbyopia [8]Individuals with eye disease, entropion of the eyelids, trichiasis [9]Individuals with a definitive diagnosis of dry eye [10]Individuals using eye drops to treat eye diseases [11]Individuals with refractive error and not properly corrected [12]Individuals undergoing LASIK surgery [13]Individuals with severe astigmatism [14]Individuals who are thought to have eye strain due to dysregulation such as neurosis [15]Individuals with >=30.0kg/m2 BMI [16]Individuals with drug or food allergies [17]Individuals who have a habit of continuing to take functional foods, health foods, and supplements for the purpose of improving eye function, or who plan to take them during the study period, now and within the past 3 months [18]Individuals who are currently or within the last 3 months taking health foods containing enzymatic decomposed rooster combs, hyaluronic acid, collagen, proteoglycans, elastin, or their precursors during the study period or individuals planning to take new those products [19]Individuals with alcohol intake exceeding 60g/day [20]Individuals who may significantly change their lifestyle during the study period [21]Individuals who work at night etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| DEQS,Visual Analogue Scale,BUT(Tear film break-up time),Schirmer's test | — |
Secondary
| Measure | Time frame |
|---|---|
| Visual acuity examination, Intraocular pressure examination,Refraction inspection,Anti-aging QOL common questionnaire | — |
Countries
Japan
Contacts
Public ContactToshiyasu Tamura
TES Holdings Co., Ltd. Department of Clinical Trial
Outcome results
None listed